[Clinical practice guideline for the diagnosis and treatment of cardiorenal syndrome (2023 Edition)].

The guideline was co-authored by a working group composed of multidisciplinary experts in nephrology, cardiology, critical care medicine, and evidence-based medicine. It focused on eight clinical issues concerning prediction, diagnosis and assessment of cardiorenal syndrome, prevention, treatment of drugs and their selection, mechanical circulatory support and blood purification therapy, heart and/or kidney transplantation, treatment of major complications, multidisciplinary combination therapy, and special diagnosis and treatment in children and pregnant women, mainly based on evidence-based evidence of cardiorenal syndrome, heart failure and chronic kidney disease. Meanwhile, the domestic and foreign clinical guidelines in related fields were referenced to put forward recommendations. The present guideline aims to guide and standardize the clinical practice of diagnosis, prevention, treatment and management of cardiorenal syndrome, promote the development of clinical trials, and improve the level of prevention, treatment and scientific research.本指南由肾脏病学、心血管病学、重症医学、循证医学等多学科专家组成的编写委员会共同撰写，针对心肾综合征的预测、诊断和病情评估、预防、治疗药物及其选择、器械循环辅助装置和血液净化治疗、心脏和（或）肾脏移植、主要并发症治疗、多学科联合治疗以及儿童与妊娠女性诊疗特殊性8个临床问题，主要基于心肾综合征、心力衰竭及慢性肾脏病的循证证据，同时借鉴和参考了相关领域的国内外临床指南，提出推荐/建议意见。目的在于指导、规范心肾综合征的诊断、预防、治疗与管理的临床实践，同时推动临床试验的开展，提高疾病防治和科研水平。.